2006
DOI: 10.1001/jama.295.17.2046
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes

Abstract: Based on available evidence, initiation of statin therapy within 14 days following onset of ACS does not reduce death, MI, or stroke up to 4 months.

Search citation statements

Order By: Relevance

Paper Sections

Select...
135
16
7
3

Citation Types

5
69
0
6

Year Published

2006
2006
2026
2026

Publication Types

Select...
137
14
8

Relationship

13
146

Authors

Journals

citations

Cited by 158 publications

(80 citation statements)
references

References 47 publications

5
69
0
6
Order By: Relevance
How this paper cites the one you are viewing
“…We also analyzed the clinical outcome at 1 month, and there were no significant differences in the primary endpoint between the groups. This is consistent with and expands on 2 meta-analyses (20,21), both of which also showed that beneficial effects of statins were apparent only after more than 4 months.…”
Section: Discussion
supporting
confidence: 88%
How this paper cites the one you are viewing
“…We also analyzed the clinical outcome at 1 month, and there were no significant differences in the primary endpoint between the groups. This is consistent with and expands on 2 meta-analyses (20,21), both of which also showed that beneficial effects of statins were apparent only after more than 4 months.…”
Section: Discussion
supporting
confidence: 88%
How this paper cites the one you are viewing
“…As regards the impact of intensive statin therapy on cardiovascular morbidity and mortality and in concordance with the present study; Choudhry et al had shown the non‐superiority of intensive statin therapy in decreasing incidence of MACE in elderly patients with ACS after a long term follow‐up period . Also, a meta‐analysis of randomized controlled trials failed to demonstrate a reduction in the composite primary end point (death, myocardial infarction, or stroke) after 1 and 4 months in ACS patients treated early with intensive doses of statins . On the other hand, PROVE IT–TIMI 22 trial showed that intensive statin therapy after ACS was associated with major protection against MACE after a follow‐up period of 24 months.…”
Section: Discussion
supporting
confidence: 87%
How this paper cites the one you are viewing
“…Our findings are similar to and extend on a recent meta-analysis ex-ploring the effects of statin use in ACS. 34 Similar to our findings, Briel et al 34 found no evidence of benefit through 4 months. This may not be a surprising finding since 1 potential benefit of statins may be plaque stabilization, which may take several months to occur.…”
Section: Comment
supporting
confidence: 91%